Fulgent Genetics (FLGT) Other Non-Current Assets (2015 - 2026)

Fulgent Genetics has disclosed Other Non-Current Assets across 12 years of filings, most recently posting $25.0 million for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $25.0 million, down 23.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.0 million (down 23.64% YoY), and the FY2025 annual result was $22.9 million, down 31.69% from the prior year.
• Other Non-Current Assets came in at $25.0 million for Q1 2026 at Fulgent Genetics, up from $22.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $61.8 million in Q2 2022 to a low of $22.9 million in Q4 2025.
• The 5-year median for Other Non-Current Assets is $34.8 million (2022), against an average of $37.3 million.
• Across the five-year window, Other Non-Current Assets surged 594.36% in 2022 and plunged 40.5% in 2025, its largest moves.
• Fulgent Genetics' Other Non-Current Assets stood at $44.1 million in 2022, then slipped by 20.9% to $34.9 million in 2023, then declined by 4.13% to $33.5 million in 2024, then tumbled by 31.69% to $22.9 million in 2025, then gained by 9.28% to $25.0 million in 2026.
• The last three Other Non-Current Assets figures came in at $25.0 million (Q1 2026), $22.9 million (Q4 2025), and $23.2 million (Q3 2025), per Business Quant data.